A bone biopsy study of 56 CKD stage 3–4 patients showed that at a sclerostin threshold of 55.5 pmol/L, the AUC for diagnosing low bone turnover was 0.70 (76.5% sensitivity, 64.5% specificity) [142]. Here, SOST is linked to chronic kidney disease.